Menu

 

Editorial

Clinical trial data for all drugs in current use

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7304 (Published 29 October 2012)
Cite this as: BMJ 2012;345:e7304

Related articles

Letter: We need access to data on all clinical trials, not just some

Published 26 November 2012; BMJ 345 doi: 10.1136/bmj.e8001

Letter: Additional requirements for complex interventions

Published 26 November 2012; BMJ 345 doi: 10.1136/bmj.e8003

Letter: Introducing the HRA’s new system

Published 26 November 2012; BMJ 345 doi: 10.1136/bmj.e8005

News: Europe’s drug agency will publish clinical trial data for new products from 2014

Published 26 November 2012; BMJ 345 doi: 10.1136/bmj.e8061

News: MPs are to investigate need for drug companies to share clinical trial data

Published 22 November 2012; BMJ 345 doi: 10.1136/bmj.e7980

Editorial: The new BMJ policy on sharing data from drug and device trials

Published 20 November 2012; BMJ 345 doi: 10.1136/bmj.e7888

Letter: John Bell’s conflict of interest

Published 13 November 2012; BMJ 345 doi: 10.1136/bmj.e7701

News: GSK backs BMJ’s new policy to publish only studies with full access to data

Published 1 November 2012; BMJ 345 doi: 10.1136/bmj.e7404

Editor's Choice: Open data: seize the moment

Published 31 October 2012; BMJ 345 doi: 10.1136/bmj.e7332

Observations: Open letter to Roche about oseltamivir trial data

Published 29 October 2012; BMJ 345 doi: 10.1136/bmj.e7305

Feature: Tamiflu: the battle for secret drug data

Published 29 October 2012; BMJ 345 doi: 10.1136/bmj.e7303

Feature: Rosiglitazone: what went wrong?

Published 6 September 2010; BMJ 341 doi: 10.1136/bmj.c4848

Analysis: Neuraminidase inhibitors—the story behind the Cochrane review

Published 8 December 2009; BMJ 339 doi: 10.1136/bmj.b5164

News roundup [abridged versions appear in the paper journal]: Manufacturer admits increase in suicidal behaviour in patients taking paroxetine

Published 18 May 2006; BMJ 332 doi: 10.1136/bmj.332.7551.1175

Open data campaign

Tamiflu: the battle for secret drug data

Academics plea for politicians to tackle problem of missing data

Open letter to Roche about oseltamivir trial data

GSK backs BMJ’s new policy to publish only studies with full access to data

See more

Editorial: Autologous blood products in musculoskeletal medicine

Published 10 May 2013; BMJ 346 doi: 10.1136/bmj.f2979

Research News: Prophylactic penicillin cuts risk of recurrent cellulitis

Published 8 May 2013; BMJ 346 doi: 10.1136/bmj.f2893

Editorial: The European Medicines Agency’s plans for sharing data from clinical trials

Published 8 May 2013; BMJ 346 doi: 10.1136/bmj.f2961

This article has been cited by other articles:

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls